ATRA and Carfilzomib in Plasma Cell Myeloma Patients
Clinical trial NCT06536413 · RECRUITING
Trial details
- NCT number
- NCT06536413
- Sponsor
- The Methodist Hospital Research Institute
- Status
- RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-07-29
- Primary completion
- 2029-07-01
- Enrollment
- 42
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.